These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26716356)

  • 21. An automated electrophysiological assay for differentiating Ca(v)2.2 inhibitors based on state dependence and kinetics.
    Swensen AM; Niforatos W; Vortherms TA; Perner RJ; Li T; Schrimpf MR; Scott VE; Lee L; Jarvis MF; McGaraughty S
    Assay Drug Dev Technol; 2012 Dec; 10(6):542-50. PubMed ID: 22428804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system.
    Cao X; Lee YT; Holmqvist M; Lin Y; Ni Y; Mikhailov D; Zhang H; Hogan C; Zhou L; Lu Q; Digan ME; Urban L; Erdemli G
    Assay Drug Dev Technol; 2010 Dec; 8(6):766-80. PubMed ID: 21133679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks.
    Harmer AR; Abi-Gerges N; Easter A; Woods A; Lawrence CL; Small BG; Valentin JP; Pollard CE
    J Pharmacol Toxicol Methods; 2008; 57(1):30-41. PubMed ID: 17980627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels.
    Vortherms TA; Swensen AM; Niforatos W; Limberis JT; Neelands TR; Janis RS; Thimmapaya R; Donnelly-Roberts DL; Namovic MT; Zhang D; Brent Putman C; Martin RL; Surowy CS; Jarvis MF; Scott VE
    Inflamm Res; 2011 Jul; 60(7):683-93. PubMed ID: 21394563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca
    Wall MJ; Subasinghe NL; Winters MP; Lubin ML; Finley MFA; Qin N; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3780-3783. PubMed ID: 30337231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors.
    Dai G; Haedo RJ; Warren VA; Ratliff KS; Bugianesi RM; Rush A; Williams ME; Herrington J; Smith MM; McManus OB; Swensen AM
    Assay Drug Dev Technol; 2008 Apr; 6(2):195-212. PubMed ID: 18471074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels.
    John VH; Dale TJ; Hollands EC; Chen MX; Partington L; Downie DL; Meadows HJ; Trezise DJ
    J Biomol Screen; 2007 Feb; 12(1):50-60. PubMed ID: 17092914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening quality for Ca2+-activated potassium channel in IonWorks Quattro is greatly improved by using BAPTA-AM and ionomycin.
    Ido K; Ohwada T; Yasutomi E; Yoshinaga T; Arai T; Kato M; Sawada K
    J Pharmacol Toxicol Methods; 2013; 67(1):16-24. PubMed ID: 23138150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ion channel pharmacology under flow: automation via well-plate microfluidics.
    Spencer CI; Li N; Chen Q; Johnson J; Nevill T; Kammonen J; Ionescu-Zanetti C
    Assay Drug Dev Technol; 2012 Aug; 10(4):313-24. PubMed ID: 22574656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of escin as a perforating agent on the IonWorks quattro automated electrophysiology platform.
    Morton MJ; Main MJ
    J Biomol Screen; 2013 Jan; 18(1):128-34. PubMed ID: 22923788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation and optimization of novel high-throughput assays for human epithelial sodium channels.
    Chen MX; Gatfield K; Ward E; Downie D; Sneddon HF; Walsh S; Powell AJ; Laine D; Carr M; Trezise D
    J Biomol Screen; 2015 Feb; 20(2):242-53. PubMed ID: 25278498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of automated patch clamp assays for canonical transient receptor potential channels TRPC3, 6, and 7.
    McPate M; Bhalay G; Beckett M; Fairbrother S; Gosling M; Groot-Kormelink PJ; Lane R; Kent T; Van Diepen MT; Tranter P; Verkuyl JM
    Assay Drug Dev Technol; 2014 Jun; 12(5):282-92. PubMed ID: 24906109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered synaptic transmission at olfactory and vomeronasal nerve terminals in mice lacking N-type calcium channel Cav2.2.
    Weiss J; Pyrski M; Weissgerber P; Zufall F
    Eur J Neurosci; 2014 Nov; 40(10):3422-35. PubMed ID: 25195871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
    Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE
    J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological studies of Cav3.1 T-type calcium channels using automated patch-clamp techniques.
    Choi KH; Song C; Cheong CS; Rhim H
    Gen Physiol Biophys; 2011 Mar; 30(1):100-5. PubMed ID: 21460418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Huwentoxin-XVI, an analgesic, highly reversible mammalian N-type calcium channel antagonist from Chinese tarantula Ornithoctonus huwena.
    Deng M; Luo X; Xiao Y; Sun Z; Jiang L; Liu Z; Zeng X; Chen H; Tang J; Zeng W; Songping Liang
    Neuropharmacology; 2014 Apr; 79():657-67. PubMed ID: 24467846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. omega-conotoxin GVIA alters gating charge movement of N-type (CaV2.2) calcium channels.
    Yarotskyy V; Elmslie KS
    J Neurophysiol; 2009 Jan; 101(1):332-40. PubMed ID: 18971294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons.
    Wu ZZ; Chen SR; Pan HL
    Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological and molecular evidence of L-(Cav1), N- (Cav2.2), and R- (Cav2.3) type Ca2+ channels in rat cortical astrocytes.
    D'Ascenzo M; Vairano M; Andreassi C; Navarra P; Azzena GB; Grassi C
    Glia; 2004 Mar; 45(4):354-63. PubMed ID: 14966867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
    Ramanathan S; Tkatch T; Atherton JF; Wilson CJ; Bevan MD
    J Neurophysiol; 2008 Feb; 99(2):442-59. PubMed ID: 18094105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.